Sobre a EDCTP
We are in the process of launching our new website. Please come back later to check it out.
A Parceria entre a Europa e os Países em Desenvolvimento para a Realização de Ensaios Clínicos (EDCTP) tem por objectivo acelerar o desenvolvimento de fármacos, vacinas, microbicidas e diagnósticos novos ou melhorados para o VIH/SIDA, a tuberculose e a malária, com particular incidência em ensaios clínicos da fase II e III na África subsaariana.
Portuguese title
Descubra a estratégia da EDCTP na luta contra HIV/AIDS, tuberculose e malária.
Portuguese title
Descubra a estratégia da EDCTP na luta contra HIV/AIDS, tuberculose e malária.
Portuguese title
Descubra a estratégia da EDCTP na luta contra HIV/AIDS, tuberculose e malária.
Latest news
World TB Day: EDCTP investments in TB research rise to EUR 127 million
World Tuberculosis Day on 24 March 2019 is themed ‘It’s time’. As the World Health Organisation (WHO) explains, the theme underlines “the urgency to act” on the commitments made by global leaders in September 2018. At the United Nations TB…
ASAAP clinical study of malaria treatment for children has started
A large clinical study evaluating a triple plus combination of antimalarials for children has started in Ghana. The study is coordinated by Dr. Oumou Maiga-Ascofare of the Kumasi Centre for Collaborative Research at the Kwame Nkrumah University of Science and…